Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/25/25 18:52 | 6/23/25 | OKUR | Health | Drug | Pharmaceutical Preparations | Saccomano Nicholas A | CO | DO | P,CEO | 1 | S | 0 | 2.39 | 0 | 0 | 4 | D | |||||||||||||||
6/25/25 18:49 | 6/23/25 | OKUR | Health | Drug | Pharmaceutical Preparations | Leverone Jason A. | CO | O | CFO | 1 | S | -1 | 2.38 | 0 | 0 | 13 | D | |||||||||||||||
5/19/25 17:33 | 5/15/25 | OKUR | Health | Drug | Pharmaceutical Preparations | Cormorant Asset Management, LP | MA | H | Former 1 | 2 | S | -3,411 | 1.86 | 0 | -1,838 | 1,813 | I | |||||||||||||||
5/19/25 16:43 | 5/15/25 | OKUR | Health | Drug | Pharmaceutical Preparations | Acorn Bioventures, L.P. | NY | T | 1 | P | 2,590 | 1.85 | 0 | 1,400 | 97 | 2,840 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |